This dual location (cellular and extracellular) explains the prognostic impact of these proteins in AML and ALL patients that result from the combination of their effects on the proliferation and survival of blast cells, but also from extra-cellular mechanisms linked to secreted S100A8 and. The gene discussed is S100A8; the disease is acute myeloid leukemia.